With ubituximab, a high percentage of patients maintained no signs of disease activity.

Published Date: 01 Mar 2023

After receiving ublituximab treatment, the majority of patients with relapsing multiple sclerosis showed that they could achieve and maintain no evidence of disease activity.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Base-edited T-cell therapy offers additional hope for treating resistant leukemia.

2.

"We Caught It Early": Advantage or Disadvantage?

3.

The Effect of Common Steroids on Cancer Treatments.

4.

Q&A: Why adolescents and young adults with cancer are falling behind

5.

Radiotherapy of cancer: Researchers enable better cancer treatment using existing medical equipment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot